Quite a few brokerages are of the opinion that the stocks of VCYT would be posting a sales sum of $32.19 for the present quarter. According to quite a few reports, three of the analysts have already deposited their estimates regarding the earnings of the company. The highest range has gone up to $33.27 million, while the lowest one comes in at $30.80 million. The company did report a sales value of $29.73 million for the previous year, which is indicative of a positive annual growth rate of about 8.3%. The company will be posting its next quarterly earnings report on the 23rd of February.
The Quarterly Earnings of VCYT
VCYT posted their last results of quarterly earnings on the 2nd of November. The biotechnology company had reported an EPS of around $0.08 for that quarter, which competed with the consensus estimate of $0.21. The company had a negative return on its equity at 13.35%, along with a negative net margin of about 27.49%. The revenue earned by the firm for the quarter was $31.12 million, which was more than the analyst consensus of about $24.85 million.
There are quite a few research analysts who have commented on the stocks of VCYT. Zacks Investment Research has already increased the shares of the company from a rating of hold to a rating of buy, along with a price target set at $54- in a research report that was published on the 18th of December.
BidaskClub has also lowered the ratings of the company from buy to hold in a 30th December research report. BTIG Research has increased the price objective on the company from $42 to $56, along with a rating of buy in a 17th December research report. ValuEngine has decreased the shares of the company from a rating of buy to a rating of hold in a 1st December research report.
One investment analyst covering the stocks of VCYT has already issued the company with a rating of sell, while three of them have given it a rating of hold. Six investment analysts have given a rating of buy to the company. Currently, VCYT has a rating of buy, with a price objective set at $47.57.